Beneficial effect of cabergoline, new long-lasting D2 agonist in the treatment of Parkinson's disease. (Q39231169)
Jump to navigation
Jump to search
scientific article published on June 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Beneficial effect of cabergoline, new long-lasting D2 agonist in the treatment of Parkinson's disease. |
scientific article published on June 1994 |
Statements
Beneficial effect of cabergoline, new long-lasting D2 agonist in the treatment of Parkinson's disease (English)
A D Korczyn
2 references
J M Rabey
P Nissipeanu